// App-Quantinova.ai

PB1268 : Anti-Thrombotic Effects of the Proteasome Inhibitor Carfilzomib on the Endothelium

Researchers

Presenter

  • A. Hjazi

Principal Investigators

  • T. Page

  • T. McKinnon

Medical Centers

  • Imperial College, London, United Kingdom

  • NCRI and Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • von Willebrand factor

  • Tumor necrosis factor

Drug/Treatment

  • carfilzomib Intravenous

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved